Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-06FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Mylan Pharmaceuticals Inc., enabling continued marketing of the…
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
FDA label_change · 2025-04-16FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-14FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Digoxin submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. [NA]
RESOLVE-AF is a clinical evaluation of Cortex's Ablacath Mapping Catheter and Ablamap System using electrographic flow mapping to identify e…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
Completed Canadian registry study evaluating edoxaban (Lixiana) in patients with atrial fibrillation or atrial flutter and valvular heart di…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Clinical Cohort Study - TRUST
TRUST is a clinical cohort study that is currently recruiting to investigate various cardiac arrhythmias. The document lists conditions incl…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter [NA]
This clinical trial update reports the completion of a feasibility study evaluating an optically guided radiofrequency ablation catheter. Th…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Risk Factors in Tachycardiomyopathy
Clinical trial investigating risk factors for tachycardia-induced cardiomyopathy, focusing on atrial fibrillation, atrial flutter, and prema…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter [Phase 4]
A Phase 4 clinical trial comparing Refralon with Amiodarone for cardioversion in patients with paroxysmal atrial fibrillation and atrial flu…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation [NA]
This clinical trial update reports on the use of Refralon in patients with recurrent atrial fibrillation (paroxysmal and persistent) after c…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate. [Phase 3]
Phase 3 clinical trial comparing oral bisoprolol to IV diltiazem for rate control in atrial fibrillation or atrial flutter with rapid ventri…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment
This trial validates a novel smartphone-based method for monitoring heart rhythm at home. It targets atrial fibrillation, atrial flutter, an…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablation Vs. Radiofrequency Ablation: a Preliminary Randomized Controlled Study [NA]
This clinical trial entry outlines a preliminary randomized study comparing pulsed field ablation versus radiofrequency ablation for mitral …
-
FDA approval · 2025-02-24FDA Approved: DOFETILIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
FDA approved a supplemental application for the generic DOFETILIDE from Dr. Reddy's Labratories Inc., authorizing the generic product.
-
FDA approval · 2025-02-21FDA Approved: DILTIAZEM HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved a new injectable diltiazem hydrochloride in sodium chloride under an original NDA from WG Critical Care, LLC. This parenteral f…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia [NA]
An exploratory clinical trial evaluating a Focal Pulse Ablation System for treating atrial arrhythmias, currently recruiting for typical atr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Pulmonary Vein Isolation in Typical Atrial Flutter and Heart Failure [NA]
The document describes a clinical trial evaluating pulmonary vein isolation for patients with typical atrial flutter and heart failure, with…
-
FDA approval · 2025-02-04FDA Approved: PROCAINAMIDE HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approved Caplin Steriles Limited's original ANDA for Procainamide hydrochloride, a generic antiarrhythmic drug.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation Catheter [Phase 1]
Phase 1 trial update for the LINEAR II LME-159 multi-electrode linear ablation catheter in cavotricuspid isthmus-dependent right atrial flut…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Get With the Guidelines Atrial Fibrillation Registry
Clinical trial registry entry for the Get With the Guidelines Atrial Fibrillation Registry, currently recruiting to study atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: FREEZE-AFIB Post-Market Study
Post-market study update for AtriCure's FREEZE-AFIB device in atrial fibrillation and atrial flutter; trial has completed with results poste…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Cardiac Magnetic Resonance Predictors of Outcome of Rhythm Control in Patients with Atrial Fibrillation/Flutter
A clinical trial update notes a study evaluating whether cardiac magnetic resonance imaging can predict outcomes of rhythm-control treatment…